|
KIAA0090 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.599600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.861640E-01 |
| Normal-vs-Stage2 |
2.954000E-01 |
| Normal-vs-Stage3 |
3.405200E-01 |
| Normal-vs-Stage4 |
1.344390E-01 |
| Stage1-vs-Stage2 |
5.884500E-02 |
| Stage1-vs-Stage3 |
3.582100E-02 |
| Stage1-vs-Stage4 |
1.215910E-02 |
| Stage2-vs-Stage3 |
8.068400E-01 |
| Stage2-vs-Stage4 |
8.153400E-01 |
| Stage3-vs-Stage4 |
5.853400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.963000E-01 |
| Normal-vs-AfricanAmerican |
1.091850E-02 |
| Normal-vs-Asian |
5.195200E-01 |
| Caucasian-vs-AfricanAmerican |
1.029580E-02 |
| Caucasian-vs-Asian |
5.164200E-01 |
| AfricanAmerican-vs-Asian |
7.490100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.058400E-01 |
| Normal-vs-Female |
4.893000E-01 |
| Male-vs-Female |
1.698030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.538600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.033200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.967400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.534600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.048600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.483000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.792200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.113200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.247800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.367800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.742180E-02 |
| Normal-vs-Grade 2 |
2.223000E-01 |
| Normal-vs-Grade 3 |
1.296780E-01 |
| Normal-vs-Grade 4 |
3.919400E-01 |
| Grade 1-vs-Grade 2 |
4.078100E-02 |
| Grade 1-vs-Grade 3 |
3.276100E-03 |
| Grade 1-vs-Grade 4 |
1.331570E-02 |
| Grade 2-vs-Grade 3 |
5.659000E-03 |
| Grade 2-vs-Grade 4 |
7.508100E-02 |
| Grade 3-vs-Grade 4 |
8.574600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.296200E-02 |
| Normal-vs-ccB subtype |
7.042200E-01 |
| ccA subtype-vs-ccB subtype |
2.554000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.997800E-01 |
| Normal-vs-N1 |
9.131400E-01 |
| N0-vs-N1 |
9.130600E-01 |
|
|
